Ubs Group Ag Lumos Pharma, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 6,557 shares of LUMO stock, worth $28,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,557

Holding current value

$28,457

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.45 - $4.05 $9,507 - $26,555	6,557 New	6,557 $25,000
Q1 2024 May 13, 2024	BUY	$2.64 - $3.22 $9,659 - $11,781	3,659 Added 4944.59%	3,733 $10,000
Q4 2023 Feb 09, 2024	BUY	$2.81 - $4.27 $207 - $315	74 New	74 $0
Q4 2022 Feb 08, 2023	BUY	$3.05 - $9.52 $3,937 - $12,290	1,291 Added 173.99%	2,033 $7,000
Q3 2022 Nov 10, 2022	SELL	$7.35 - $9.05 $8,775 - $10,805	-1,194 Reduced 61.67%	742 $6,000
Q2 2022 Aug 10, 2022	SELL	$6.68 - $9.39 $1,242 - $1,746	-186 Reduced 8.77%	1,936 $15,000
Q1 2022 May 16, 2022	SELL	$6.58 - $10.09 $22,845 - $35,032	-3,472 Reduced 62.07%	2,122 $20,000
Q4 2021 Feb 14, 2022	BUY	$6.84 - $10.04 $35,027 - $51,414	5,121 Added 1082.66%	5,594 $39,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $11.36 $2,664 - $4,112	362 Added 326.13%	473 $4,000
Q2 2021 Aug 13, 2021	SELL	$9.75 - $13.44 $11,953 - $16,477	-1,226 Reduced 91.7%	111 $1,000
Q1 2021 May 12, 2021	BUY	$11.58 - $31.11 $4,574 - $12,288	395 Added 41.93%	1,337 $15,000
Q4 2020 Feb 11, 2021	SELL	$13.61 - $35.91 $9,009 - $23,772	-662 Reduced 41.27%	942 $34,000
Q3 2020 Nov 12, 2020	BUY	$13.25 - $16.5 $19,782 - $24,634	1,493 Added 1345.05%	1,604 $23,000
Q2 2020 Jul 31, 2020	SELL	$7.76 - $16.99 $9,040 - $19,793	-1,165 Reduced 91.3%	111 $2,000
Q1 2020 May 01, 2020	BUY	$0.89 - $8.85 $1,135 - $11,292	1,276 New	1,276 $11,000

Others Institutions Holding LUMO

# of Institutions

Shares Held

2.2M

Call Options Held

Put Options Held

Private Advisor Group, LLC

745K
Shares

$3.23 Million
0.02% of portfolio
Goldman Sachs Group Inc New York, NY

362K
Shares

$1.57 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

244K
Shares

$1.06 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

214K
Shares

$927,952
0.0% of portfolio
Jefferies Group LLC New York, NY

121K
Shares

$523,625
0.01% of portfolio

View Full List

About LUMOS PHARMA, INC.

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

More about LUMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account